Chemistry: analytical and immunological testing – Metal or metal containing – Present in biological fluids
Patent
1994-11-17
1996-10-01
Soderquist, Arlen
Chemistry: analytical and immunological testing
Metal or metal containing
Present in biological fluids
436 63, 436 73, 436 79, 436 99, 436174, 436181, G01N 33493
Patent
active
055610676
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
The present invention relates to analytical methods for use in medicine and, more specifically, to a method for evaluating the extent of a lithogenesis process intensity and for determining the composition of lithogenic urate salts in urolithiasis.
BACKGROUND OF THE INVENTION
The problems of investigating the dynamic aspects of a lithogenesis process in the human organism, of studying its intensity, of determining the salt composition in the course of a lithogenesis process are currently being researched. Knowledge in this field makes it possible to prevent the formation of urate calculi, to introduce timely corrections into the lithogenesis process, to prescribe and carry out individual therapeutic treatment for urolithiasis cases.
Known in the prior art are methods for predicting urolithiasis based upon detecting a lithogenesis process, such as, e.g. a prediction method based upon detection of urate salt crystals in freshly discharged urine or in urine analyzed Shortly after urination (Ref. V. Ye. Predtechensky "Guide for Clinical Laboratory Investigations", 1964 Medicina Publishers, pp. 420-446), or a method for predicting urolithiasis (SU, A, 1 629 846) based upon evaluation of the crystal-forming activity of urine by mixing solutions of calcium chloride, sodium oxalate and urine, followed by holding the resultant mixture and then counting the number of crystals formed.
However, the above-cited methods are aimed only at detecting a lithogenesis process, and they do not allow the determination to be made as to the extent of this process intensity.
Equally known in the prior art is a method for predicting urolithiasis, in which it is recommended to evaluate the extent of risk of calcium phosphate crystallization in urine by counting the number of crystals thus-formed and having a specific size using recommended mathematical procedures (refer, please, to the "Urological Research", No. 2, 15, 1987, Springer-Verlag, H.-G. Tiselius, "Measurement of the Risk of Calcium Phosphate Crystallization in Urine", pp. 79-81). The latter methods calls for sophisticated mathematical calculations, and its only purpose is to detect the fact of a lithogenesis process.
Also known in the prior art is a method for predicting of urolithiasis (PCT/SU 91/00140), by preparing a protein solution, e.g. albumin solution is added to a urine sample, the resultant mixture is subjected to drying and, if a 100%-crystallization of the urine sample takes place, a urolithiasis case is predicted. The latter method is also aimed at revealing a lithogenesis process, and it cannot be used for evaluating the extent of intensity of a lithogenesis process.
Moreover, there are known in the prior art methods for determining the composition of urate salts participating in urolithiasis (V. Ye. Predtechensky "Guide for Clinical Laboratory Investigations", 1964 Medicina Publishers, Moscow, pp. 452-454; Wandt M., Underhill L. "Brit. J. Urol.", 1988 61 No. 6 478-481; Schubert G., Brien G., Adam K. "Z. Klin. Med.", 1989, 44, No. 11 , 923-928; Nichino T., Sakura T., Sato T., Koiso K., Kaneko S. "Jap. J. Nephrol.", 1987, 29, No. 5, 571-575). All of the above-cited methods are based upon study of the urine constituents (salt deposit, sand, concretions) by the physico-chemical route using adsorption, ion exchange, such as, e.g. chromatography, using X-ray structural analysis, X-ray spectral analysis, thermal analysis involving study of nuclear magnetic resonance, electron para-magnetic resonance and other spin effects.
All of the above-cited methods are suitable only for study of already formed calculi discharged from the human body, and they unable to determine the chemical nature of nascent calculi at early urolithiasis stages, and that of calculi already fully formed, but not withdrawn from the body.
There exists in the prior art no method for determining the chemical composition of calculi-forming urate salts at early urolithiasis stages, or for determining that of calculi fully formed, but not discharged from the organism.
DES
REFERENCES:
patent: 2862796 (1958-12-01), Gomberg
patent: 4877206 (1989-07-01), Heinz
patent: 5366899 (1994-11-01), Shabalin et al.
X. Martin et al. Kidney Int. 1985, 28, 636-639.
K. A. Edyvane et al. Clin. Chim. Acta 1986, 157, 81-88.
E. M. Worcester et al. Am. J. Physiol. 1988, 255, F1197-F1205.
Predtechensky, V. E. Manual for Clinical Laboratory Studies Publishing House Medicine, 1964, pp. 420, 425-431, 445-446 (& an English translation of p. 427).
Predtechensky, V. E. Manual for Clinical Laboratory Studies Publishing House Medicine, 1964. pp. 452-454 (& an English translation thereof).
Schubert; Gernot, et al. "Crystalloptical and Microprobe . . . " Z. Klin. Med. 44 (1989), pp. 923-928. (& an English translation thereof).
Tiselius, H. G. "Measurement of the Risk of Calcium . . . " Urological Research, vol. 15, (1987) pp. 79-81.
Wandt, M. A. E., et al. "Covanance Biplot Analysis . . . " British Journal of Urology, vol. 61, (1988) pp. 474-481.
Nishino, Tadashi, et al. "An approach to dissolving kidney . . . " Japanese Journal of Nephrology, vol. 29, No. 5 (1987), pp. 571/73-575/77.
Shabalin Vladimir N.
Shatokhina Svetlana N.
LandOfFree
Method of determining the severity of a lithogenesis condition a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining the severity of a lithogenesis condition a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining the severity of a lithogenesis condition a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1501682